{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:32:14Z","timestamp":1777984334298,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital, Linkou","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-026-04760-5","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T01:23:07Z","timestamp":1772155387000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical outcomes of a generic versus brand-name clopidogrel for secondary prevention in patients with ischemic stroke: a nationwide retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Ching-Jung","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Hao","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Chih","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Pin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzyy-Jer","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0361-6348","authenticated-orcid":false,"given":"Pao-Hsien","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"issue":"10","key":"4760_CR1","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S1474-4422(21)00252-0","volume":"20","author":"GBDS Collaborators","year":"2021","unstructured":"Collaborators GBDS. Global, regional, and national burden of stroke and its risk factors, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20(10):795\u2013820.","journal-title":"Lancet Neurol"},{"issue":"3","key":"4760_CR2","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1161\/CIRCRESAHA.116.308398","volume":"120","author":"AK Boehme","year":"2017","unstructured":"Boehme AK, Esenwa C, Elkind MS. Stroke Risk Factors, Genetics, and Prevention. Circ Res. 2017;120(3):472\u201395.","journal-title":"Circ Res"},{"key":"4760_CR3","doi-asserted-by":"crossref","unstructured":"Rajsic Sea. Economic burden of stroke: a systematic review on post-stroke care. Eur J Health Econ. 2019;20.","DOI":"10.1007\/s10198-018-0984-0"},{"key":"4760_CR4","doi-asserted-by":"publisher","first-page":"8703627","DOI":"10.1155\/2020\/8703627","volume":"2020","author":"G Patti","year":"2020","unstructured":"Patti G, Micieli G, Cimminiello C, Bolognese L. The Role of Clopidogrel in 2020: A Reappraisal. Cardiovasc Ther. 2020;2020:8703627.","journal-title":"Cardiovasc Ther"},{"issue":"16","key":"4760_CR5","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1093\/eurheartj\/ehp296","volume":"30","author":"L Wallentin","year":"2009","unstructured":"Wallentin L. P2Y(12) inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use. Eur Heart J. 2009;30(16):1964\u201377.","journal-title":"Eur Heart J"},{"issue":"12","key":"4760_CR6","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association\/American Stroke Association. Stroke. 2019;50(12):e344\u2013418.","journal-title":"Stroke"},{"issue":"3","key":"4760_CR7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa1800410","volume":"379","author":"SC Johnston","year":"2018","unstructured":"Johnston SC, Easton JD, Farrant M, Barsan W, Conwit RA, Elm JJ, et al. Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA. N Engl J Med. 2018;379(3):215\u201325.","journal-title":"N Engl J Med"},{"issue":"1","key":"4760_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1161\/CIRCULATIONAHA.114.014791","volume":"132","author":"Y Wang","year":"2015","unstructured":"Wang Y, Pan Y, Zhao X, Li H, Wang D, Johnston SC, et al. Clopidogrel With Aspirin in Acute Minor Stroke or Transient Ischemic Attack (CHANCE) Trial: One-Year Outcomes. Circulation. 2015;132(1):40\u20136.","journal-title":"Circulation"},{"issue":"9038","key":"4760_CR9","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","volume":"348","author":"CS Committee","year":"1996","unstructured":"Committee CS. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996;348(9038):1329\u201339.","journal-title":"Lancet"},{"key":"4760_CR10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1056\/NEJMicm066791","volume":"359","author":"L Ralph","year":"2008","unstructured":"Ralph L, Sacco MD. Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke. N Engl J Med. 2008;359:12.","journal-title":"N Engl J Med"},{"key":"4760_CR11","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/FJC.0b013e31826f36bc","volume":"60","author":"N Sambu","year":"2012","unstructured":"Sambu N, Radhakrishnan A, Curzen NA. Randomized Crossover Study Comparing the Antiplatelet Effect of Plavix Versus Generic Clopidogrel. J Cardiovasc Pharmacol. 2012;60:495\u2013501.","journal-title":"J Cardiovasc Pharmacol"},{"key":"4760_CR12","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.2147\/DDDT.S78658","volume":"9","author":"AN Zaid","year":"2015","unstructured":"Zaid AN, Al Ramahi R, Bustami R, Mousa A, Khasawneh S. Comparative fasting bioavailability of two clopidogrel formulations in healthy Mediterranean volunteers: an in vitro-in vivo correlation. Drug Des Devel Ther. 2015;9:2359\u201365.","journal-title":"Drug Des Devel Ther"},{"issue":"12","key":"4760_CR13","doi-asserted-by":"publisher","first-page":"12175","DOI":"10.18632\/aging.103394","volume":"12","author":"Z Chen","year":"2020","unstructured":"Chen Z, Mo J, Xu J, Wang A, Qin H, Zheng H, et al. Combined impact of body mass index and glycemic control on the efficacy of clopidogrel-aspirin therapy in patients with minor stroke or transient ischemic attack. Aging. 2020;12(12):12175\u201386.","journal-title":"Aging"},{"issue":"1","key":"4760_CR14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1161\/STROKEAHA.119.026845","volume":"51","author":"J Mo","year":"2020","unstructured":"Mo J, Chen Z, Xu J, Wang A, Dai L, Cheng A, et al. Efficacy of Clopidogrel-Aspirin Therapy for Stroke Does Not Exist in CYP2C19 Loss-of-Function Allele Noncarriers With Overweight\/Obesity. Stroke. 2020;51(1):224\u201331.","journal-title":"Stroke"},{"issue":"5","key":"4760_CR15","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1161\/CIR.0b013e3181ee08ed","volume":"122","author":"A Society for Cardiovascular","year":"2010","unstructured":"Society for Cardiovascular A, Interventions, Society of Thoracic S, Writing Committee M, Holmes DR Jr., Dehmer GJ, et al. ACCF\/AHA Clopidogrel clinical alert: approaches to the FDA boxed warning: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the American Heart Association. Circulation. 2010;122(5):537\u201357.","journal-title":"Circulation"},{"issue":"9","key":"4760_CR16","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1111\/cts.13590","volume":"16","author":"CC Chan","year":"2023","unstructured":"Chan CC, Tung YC, Lee KT, Chan YH, Chu PH. Clinical outcomes of generic versus brand-name clopidogrel for secondary prevention in patients with acute myocardial infarction: A nationwide cohort study. Clin Transl Sci. 2023;16(9):1594\u2013605.","journal-title":"Clin Transl Sci"},{"key":"4760_CR17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2147\/CLEP.S196293","volume":"11","author":"CY Hsieh","year":"2019","unstructured":"Hsieh CY, Su CC, Shao SC, Sung SF, Lin SJ, Kao Yang YH, et al. Taiwan\u2019s National Health Insurance Research Database: past and future. Clin Epidemiol. 2019;11:349\u201358.","journal-title":"Clin Epidemiol"},{"key":"4760_CR18","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1001\/jamainternmed.2015.3540","volume":"175","author":"AWI Hsing","year":"2015","unstructured":"Hsing AWI. 12.Nationwide Population Science: Lessons From the Taiwan National Health Insurance Research Database. JAMA Intern Med. 2015;175:1527\u20139.","journal-title":"JAMA Intern Med"},{"key":"4760_CR19","doi-asserted-by":"publisher","first-page":"e2018062","DOI":"10.4178\/epih.e2018062","volume":"40","author":"LY Lin","year":"2018","unstructured":"Lin LY, Warren-Gash C, Smeeth L, Chen PC. Data resource profile: the National Health Insurance Research Database (NHIRD). Epidemiol Health. 2018;40:e2018062.","journal-title":"Epidemiol Health"},{"issue":"7","key":"4760_CR20","doi-asserted-by":"publisher","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","volume":"52","author":"DO Kleindorfer","year":"2021","unstructured":"Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, et al. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association\/American Stroke Association. Stroke. 2021;52(7):e364\u2013467.","journal-title":"Stroke"},{"issue":"9","key":"4760_CR21","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1161\/CIRCULATIONAHA.117.033502","volume":"137","author":"KA Hicks","year":"2018","unstructured":"Hicks KA, Mahaffey KW, Mehran R, Nissen SE, Wiviott SD, Dunn B, et al. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials. Circulation. 2018;137(9):961\u201372.","journal-title":"Circulation"},{"issue":"11","key":"4760_CR22","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.jclinepi.2015.01.009","volume":"68","author":"SF Sung","year":"2015","unstructured":"Sung SF, Hsieh CY, Kao Yang YH, Lin HJ, Chen CH, Chen YW, et al. Developing a stroke severity index based on administrative data was feasible using data mining techniques. J Clin Epidemiol. 2015;68(11):1292\u2013300.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"4760_CR23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.je.2016.08.003","volume":"27","author":"LC Hung","year":"2017","unstructured":"Hung LC, Sung SF, Hsieh CY, Hu YH, Lin HJ, Chen YW, et al. Validation of a novel claims-based stroke severity index in patients with intracerebral hemorrhage. J Epidemiol. 2017;27(1):24\u20139.","journal-title":"J Epidemiol"},{"issue":"23","key":"4760_CR24","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1161\/CIRCULATIONAHA.109.895342","volume":"121","author":"PB Berger","year":"2010","unstructured":"Berger PB, Bhatt DL, Fuster V, Steg PG, Fox KA, Shao M, et al. Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. Circulation. 2010;121(23):2575\u201383.","journal-title":"Circulation"},{"issue":"1","key":"4760_CR25","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ahj.2011.04.015","volume":"162","author":"JS Berger","year":"2011","unstructured":"Berger JS, Bhatt DL, Steg PG, Steinhubl SR, Montalescot G, Shao M, et al. Bleeding, mortality, and antiplatelet therapy: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. Am Heart J. 2011;162(1):98\u2013105. e1.","journal-title":"Am Heart J"},{"issue":"9","key":"4760_CR26","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/apt.12483","volume":"38","author":"CC Lin","year":"2013","unstructured":"Lin CC, Hu HY, Luo JC, Peng YL, Hou MC, Lin HC, et al. Risk factors of gastrointestinal bleeding in clopidogrel users: a nationwide population-based study. Aliment Pharmacol Ther. 2013;38(9):1119\u201328.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"4760_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ane.13093","volume":"140","author":"AN Khanevski","year":"2019","unstructured":"Khanevski AN, Bjerkreim AT, Novotny V, Naess H, Thomassen L, Logallo N, et al. Recurrent ischemic stroke: Incidence, predictors, and impact on mortality. Acta Neurol Scand. 2019;140(1):3\u20138.","journal-title":"Acta Neurol Scand"},{"issue":"8","key":"4760_CR28","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1161\/STROKEAHA.120.028992","volume":"51","author":"C Flach","year":"2020","unstructured":"Flach C, Muruet W, Wolfe CDA, Bhalla A, Douiri A. Risk and Secondary Prevention of Stroke Recurrence: A Population-Base Cohort Study. Stroke. 2020;51(8):2435\u201344.","journal-title":"Stroke"},{"issue":"8","key":"4760_CR29","doi-asserted-by":"publisher","first-page":"105935","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105935","volume":"30","author":"M Kolmos","year":"2021","unstructured":"Kolmos M, Christoffersen L, Kruuse C. Recurrent Ischemic Stroke - A Systematic Review and Meta-Analysis. J Stroke Cerebrovasc Dis. 2021;30(8):105935.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"4760_CR30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jocn.2018.10.026","volume":"60","author":"S Zheng","year":"2019","unstructured":"Zheng S, Yao B. Impact of risk factors for recurrence after the first ischemic stroke in adults: A systematic review and meta-analysis. J Clin Neurosci. 2019;60:24\u201330.","journal-title":"J Clin Neurosci"},{"issue":"3","key":"4760_CR31","doi-asserted-by":"publisher","first-page":"I","DOI":"10.1177\/23969873221100032","volume":"7","author":"J Dawson","year":"2022","unstructured":"Dawson J, Bejot Y, Christensen LM, De Marchis GM, Dichgans M, Hagberg G, et al. European Stroke Organisation (ESO) guideline on pharmacological interventions for long-term secondary prevention after ischaemic stroke or transient ischaemic attack. Eur Stroke J. 2022;7(3):I\u2013II.","journal-title":"Eur Stroke J"},{"key":"4760_CR32","doi-asserted-by":"publisher","first-page":"1607181","DOI":"10.1155\/2019\/1607181","volume":"2019","author":"M Paciaroni","year":"2019","unstructured":"Paciaroni M, Ince B, Hu B, Jeng JS, Kutluk K, Liu L, et al. Benefits and Risks of Clopidogrel vs. Aspirin Monotherapy after Recent Ischemic Stroke: A Systematic Review and Meta-Analysis. Cardiovasc Ther. 2019;2019:1607181.","journal-title":"Cardiovasc Ther"},{"issue":"8","key":"4760_CR33","doi-asserted-by":"publisher","first-page":"e002259","DOI":"10.1161\/JAHA.115.002259","volume":"4","author":"W Xie","year":"2015","unstructured":"Xie W, Zheng F, Zhong B, Song X. Long-Term Antiplatelet Mono- and Dual Therapies After Ischemic Stroke or Transient Ischemic Attack: Network Meta-Analysis. J Am Heart Assoc. 2015;4(8):e002259.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"4760_CR34","doi-asserted-by":"publisher","first-page":"e004194","DOI":"10.1161\/CIRCOUTCOMES.117.004194","volume":"11","author":"DT Ko","year":"2018","unstructured":"Ko DT, Krumholz HM, Tu JV, Austin PC, Stukel TA, Koh M, et al. Clinical Outcomes of Plavix and Generic Clopidogrel for Patients Hospitalized With an Acute Coronary Syndrome. Circ Cardiovasc Qual Outcomes. 2018;11(3):e004194.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"4","key":"4760_CR35","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/ehjcvp\/pvy035","volume":"5","author":"VL Serebruany","year":"2019","unstructured":"Serebruany VL, Hall TS, Atar D, Agewall S, Hyun Kim M, Geudelin B, et al. Mortality and adverse events with brand and generic clopidogrel in the US Food and Drug Administration Adverse Event Reporting System. Eur Heart J Cardiovasc Pharmacother. 2019;5(4):210\u20135.","journal-title":"Eur Heart J Cardiovasc Pharmacother"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-04760-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04760-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04760-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T13:05:29Z","timestamp":1775221529000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-04760-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4760"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-04760-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7667267\/v1","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"21 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study using de-identified administrative claims data was approved by the Institutional Review Board of Linkou Chang Gung Memorial Hospital (IRB number: 202400145B0). The requirement for informed consent was waived by the IRB. This study was conducted in accordance with the principles of the Declaration of Helsinki. Not applicable (retrospective analysis of de-identified data; consent waived by the IRB).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable (no individual person\u2019s data, images, or videos are included).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"218"}}